chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Uveitis; Cystoid Macular Edema; dose 1 on 03Jun2021 11:00/dose 2 on 03Jun2021; This is a spontaneous report from a contactable consumer (patient). A 55-years-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration in left arm, on 03Jun2021 11:00, at the age of 55-year-old (not pregnant), (Lot Number: FC2336) as dose 1, single; and dose 2 via an unspecified route of administration in left arm, on 03Jun2021 at the age of 55-year-old (not pregnant), (Lot Number: EW0181) as dose 2, single; for covid-19 immunisation. The patient medical history was not reported. No other vaccine in four weeks, no other medications in two weeks. Patient did not have COVID prior vaccination. Patient had no known allergies. The patient's concomitant medications were not reported. On 28Jun2021 06:00, the patient experienced uveitis and cystoid macular edema. Events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, disability or permanent damage. Patient tested COVID post vaccination included COVID test (Nasal Swab) was negative on 02Jun2021; was negative on 10Jun2021; was negative on 21Aug2021; and was negative on 25Sep2021. Therapeutic measures were taken as a result of uveitis and cystoid macular edema included "call me/15 visits and still no cure". The outcome of events was not recovered.   No follow-up attempts are needed. No further information is expected.
SWELLING LEFT UPPER ARM, FELT LIKE FLU SYMPTOMS, JOINT PAIN, LOW GRADE FEVER, ACHINESS, AREA HOT TO TOUCH AND VERY RED.  9/16 AREA WORSE WITH RED STREAK DOWN ARM.  9/17 WORSE YET, DX WITH SERUM SICKNESS.  NOT RECOVERED YET, AT HOME AND WILL SEE MD 9/18.
Pt showed extensive bruising on her arm to me.  Bruising on deltoid, back of arm and down forearm.  Pt states her arm was only sore for a few days but just the typical arm soreness associated with the flu shot.  The bruising itself is entirely painless, it just looks really bad.
Information has been received from two Licensed practical Nurses referring to unspecified number of patients (age and gender were unknown). Information regarding concurrent conditions and medical history was not provided. On 09-JUL-2014, M-M-R II was improperly exposed to 10.9C for 17 hours. On unspecified dates after this, unspecified number of patients were vaccinated with doses of the improperly stored M-M-R II, subcutaneously 9strength, dose, dose number and lot # were not reported). Concomitant therapy was not reported. No known adverse effects. This is one of several reports received from the same source. Additional information has been requested.
Within in 2 days of the vaccine I had collapsing legs and severe headaches. The headaches lasted 2 weeks. They were debilitating. At the time I did not know what caused this. Since, I have learned that this can be a reaction to a vaccine.  Then I seemingly got better. But in April my new primary care doctor had me do a routine blood test. My liver enzymes were elevated to an emergency level. My doctor told me that I had to drop everything and go to the hospital (ER)immediately. I had never had a blood test with elevated liver enzymes before.  Since then I have been sent to a liver specialist. I am an otherwise and previously extremely healthy woman who has always treated my health holistically and by eating extremely well.
Patient received dose 1 on (14-Jul-2021), second dose received on (01-Sep-2021); This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received dose 1 on (14-Jul-2021), second dose received on (01-Sep-2021)) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003C21A and 017C21A) for COVID-19 prophylaxis.     Concurrent medical conditions included Drug allergy, Chronic kidney disease and COPD. Concomitant products included TRAZODONE for Insomnia, BUPRENORPHINE, SALBUTAMOL SULFATE (ALBUTEROL SULFATE), LISINOPRIL, GABAPENTIN and METHOCARBAMOL for an unknown indication.   On 14-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 01-Sep-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 23-Jun-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received dose 1 on (14-Jul-2021), second dose received on (01-Sep-2021)). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received dose 1 on (14-Jul-2021), second dose received on (01-Sep-2021)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2022-600713 (Patient Link).
Limping and complaining about leg/injection site hurting, entire leg and injection site swollen, red around injection site.
When period started about a week after the shot, a large clump of mass assumed to be the entire lining of the uterus all came out in one large clump. May be caused by other things but the booster shot is a possibility.
This case was reported by a consumer and described the occurrence of flu-like symptoms in a 44-year-old female subject who was vaccinated with Influenza vaccine (manufacturer unspecified) and TYKERB tablet for breast cancer. A physician or other health care professional has not verified this report. The subject's medical history included brain cancer. Concurrent medical conditions included breast cancer. Concurrent medications included KEPPRA, PROTONIX and Vitamin b12. In 2005 the patient started Lapatinib (oral) at 250 mg five times per day. On an unspecified date in October 2010 the subject received unspecified dose of Influenza vaccine (unknown). On an unspecified date in October 2010, since the vaccination with Influenza vaccine and while taking Lapatinib, the subject experienced flu-like symptoms. At the time of reporting the flu-like symptoms improved. Patient started taking TYKERB in 2005 after she had her right breast removed due to cancer. She has been taking TYKERB 1250 mg per day since 2005. She received the flu vaccine in October 2010 (date unknown) and has been experiencing flu-like symptoms since the vaccine.
Moderna COVID 19 vaccine EUA  2 days after receiving vaccine, my daughter experienced vomiting and nausea.  3 days later she had typical side effects including fever, chills, headache,  nausea PLUS vertigo.  1 week later and she still has vertigo and headache.
C/O feeling sharp pain to left are when driving home after the vaccine was given . The next morning on 5/14/19 it is hard  to move left arm and painful to touch.  Took Advil on 5/13/19 around 2:30 pm and at 0730 5/14/19. On examination the following was noted: no red streaking on arm pt can move arm but it hurts no numbness, tingling or change on sensation of L arm, hand or fingers afebrile no HA, nausea, vomiting, abd pain or diarrhea Returned to office on 5/21/19 still c/o left arm pain. Exam noted: pain is along to entire shoulder area, no swelling or redness, able to move FROM, but is very painful to lift arm above shoulder, no tingling, no numbness, no loss of perfusion, has been taking ibuprofen, no n/v, no abd pain, no ha, no fatigue, no other sx
Vaccinated and died the same day; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP).  A female patient received pneumococcal 13-val conj vac (dipht CRM197 protein) (PREVNAR 13), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "Vaccinated and died the same day". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. Additional information: The female nurse (patient) was vaccinated with Pneumonia Vaccine with Pfizer and was vaccinated and died that same day.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Vaccinated and died the same day
palpitations; body aches; fever; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations), MYALGIA (body aches), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Hashimoto's disease since an unknown date and Hypothyroidism since an unknown date. Concurrent medical conditions included Allergy to antibiotic (macrolides). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) from 01-Jan-2000 to an unknown date for an unknown indication.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (palpitations), MYALGIA (body aches), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue). At the time of the report, PALPITATIONS (palpitations), MYALGIA (body aches), PYREXIA (fever), CHILLS (chills) and FATIGUE (fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided by the reporter.   This case was linked to MOD-2021-004043 (Patient Link).
Pt experienced erythematous area 9.5 x 16.5 cm ovoid patch.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided          No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-023155 (Patient Link).   Reporter did not allow further contact
Information has been received from a physician concerning three patients between the ages of 5 and 18 who in March 2007, was vaccinated with a dose of Zostavax instead of Varivax due to human error. The patients had no symptoms. All three patients previously received their Varivax vaccinations in the past. The reporter did not have specific patient demographics. Attempt are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. Additional information has been requested.
Severe Lyme symptoms. Arthritis. Per follow-up: 8/7 Dr office has all this information. Please contact her.
About 3 weeks after I got my shot, I got a lumpy node that swelled up the size of a walnut on my left armpit. About 2 weeks it went down.
pt recv vax 13AUG98 & 310-315PM eyes were glassy, vision distracted;slanted floor effect;dizzy until 10PM;all noc did not feel nl;awoke in AM h/a;
On the night that I received the shot i broke out in a rash on my upper chest and neck. The next day, the rash spread from my ears to my feet everywhere. It seems like hives, but not like welts.
Slight skin discoloring at site of injenction; itchy skins / had itchiness on her arm; rash; slight mark at the injection site; itching at the injection site; swelling at the injection site; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE DISCOLOURATION (Slight skin discoloring at site of injenction), PRURITUS (itchy skins / had itchiness on her arm), RASH (rash), VACCINATION SITE PRURITUS (itching at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (itching at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (Slight skin discoloring at site of injenction), PRURITUS (itchy skins / had itchiness on her arm), RASH (rash) and VACCINATION SITE ERYTHEMA (slight mark at the injection site). At the time of the report, VACCINATION SITE DISCOLOURATION (Slight skin discoloring at site of injenction), PRURITUS (itchy skins / had itchiness on her arm), RASH (rash) and VACCINATION SITE ERYTHEMA (slight mark at the injection site) outcome was unknown and VACCINATION SITE PRURITUS (itching at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. Treatment medications include Topical cream.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Added second dose. Added new events.
No Additional AE; HCP called to report that the patient was given PROQUAD instead of MMR II. The PROQUAD also suffered from a non supported temperature excursion. TE cases 02418202, 02418066.  HCP states they do not wish to be contacted about this and declines  any fo; The PROQUAD also suffered from a non supported temperature excursion; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's historical medications, medical history, concurrent conditions and concomitant medications were not reported.      On 26-JUN-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) lot number w029552, expiration date 14-MAR-2024 (dose and route of administration not reported) for prophylaxis instead of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) (interchange of vaccine products). Additionally, the vaccine underwent a temperature excursion of 8 degrees Celsius for 2280 hours (product storage error). No adverse event was reported.
Patient returned to the clinic 2 hours post vaccine. She complained of throat tightness and chest pain. She was assessed by the attending MD, Benedryl, and nitro were given with relief of pain. An EKG was done and a cardiac event was ruled out.
mom awoke w/child shaking all over, eyes bugged out & arms went above head;pt was unresponsive;lasted about 6min;no apparent temp;cont crying, arms above head & jerking;EEG showed sz activity;
I woke up in the morning choking and I thought it may have been allergies. The next day I took an at home COVID-19 test that came back unknown. The next night I started to have nasal congestion, and fatigue. I took another COVID-19 test that came back positive. Over the next few days I felt extremely tired, body aches, and would still waking up choking because of the congestion. I had a telephone appointment with my doctor, and she just told me to monitor my oxygen level and if it drops too low I should go to the emergency room. I monitored my oxygen levels and they were within range. After 10 days my symptoms subsided.
he did not had a temperature but today I took it like four or five times and it started to go up/fever; allergy; lot of congestion / very congestive; difficulty in breathing / hard time breathing; chest hurt a little bit; arms were sore and may be his lymph nodes a little; arms were sore and may be his lymph nodes a little; tired; slept a little more than normal; does not feel well / he just not feel right; achy; This is a spontaneous report from a contactable consumer (parent). A 13-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 29Jul2021 12:00 (Batch/Lot Number: EW0181) (at the age of 13 years old) as single dose for covid-19 immunisation. Medical history included: he was born with cleft palate, he also has a lot of nasal congestion and a deviated septum, somewhat of compromised he could have a little bit of compromised system, and had several surgeries over the years. The patient's concomitant medications were not reported. The patient received the vaccine last 29Jul2021 at 12:00, and he just didn't had any side effect other than his arms was sore and may be his lymph nodes a little and he was tired, like he slept a little more than normal but today (04Aug2021) and yesterday (03Aug2021), the parent didn't know if it has anything to do with vaccine or not, the patient has been experiencing with lot of congestion, difficulty in breathing and his chest hurt a little bit. Yesterday (03Aug2021), the parent took his (patient) temperature twice and he did not have a temperature but today (04Aug2021) the parent took it like four or five times and it started to go up/fever at 10 in the morning it's 99.5 and then it went up after 11 o'clock at 99.6, 1:30 at 99.7 then the parent just did it again at 6:30 it was 100.7 and in between patient was given Claritin because the parent thought it was allergy related and then also the parent had just given him some Ibuprofen too to try to get the fever down. The patient was very congestive the last two days and he has hard time breathing. On an unknown date in 2021, he does not feel well and he was saying he was achy, he was saying that he just not feel right but the parent didn't know if it's allergy related or if it's around somebody after or before the shot if it has anything to do with the shot. The parent stated that the patient can't get a doctor's appointment tomorrow however he/she wants to know if he/she should be concerned because the patient did not seem well and did not want him to suffer in any way. The patient underwent lab tests which included body temperature: he did not have a temperature on 03Aug2021, he did not have a temperature on 03Aug2021, 99.5 on 04Aug2021 at 10 in the morning, 99.6 on 04Aug2021 (it went up after 11 o'clock), 99.7 on 04Aug2021 at 1:30, 100.7 on 04Aug2021 at 6:30. The adverse events were considered important medical events and resulted in physician's office visit. Outcome of the events was unknown.    No follow-up attempts are needed. No further information is expected.
Employee was diagnosed with Bell's Palsy 16 days after receiving 2nd dose of Moderna COVID 19 vaccination
Right after the vaccine was administered, started with a cough that did not improve for the next few minutes. Needed respiratory therapy
This spontaneous report was received from a pharmacist via a field representative and refers to a 62 year old male patient. The patient's concurrent conditions, medical history, and allergies were not reported. On 29-SEP-2017, the patient was vaccinated with an unspecified dose of ZOSTAVAX 19400 PFU, subcutaneous, for prevention of herpes zoster (dosage schedule, anatomical location, lot number, and expiration date were not reported). Concomitant therapies included influenza virus vaccine (reported as "flu shot") on his left arm. On approximately 02-OCT-2017 (reported as "three (3) days later"), the patient experienced one inch red injection site reaction on his right arm. Subsequently, on an unspecified date in October 2017, the patient returned to the pharmacy to sought medical attention; no treatment was reported, and laboratory diagnostic studies were not performed. At the time of reporting, the outcome of injection site erythema was unknown. The relatedness between the event and therapy with ZOSTAVAX was not reported.
Large hive/wheal approx. 12 inches around injection site.  Itching, no respiratory symptoms
I experienced a nose bleed on 14Mar2021 the day after my second vaccine dose.; This is a spontaneous report from a contactable consumer (patient).  A 51-years-old non-pregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number EW0150, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 13Apr2021 at 08:00 (51-years-old at the time of vaccination) as dose 2, single for covid-19 immunization. Medical history included allergy to sulfur drugs. Concomitant medications were not reported. The patient previously received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number ER2613, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 23Mar2021 at 08:00 (51-years-old at the time of vaccination) as dose 1, single for covid-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not received any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 14Apr2021 (day after second vaccine dose) at 12:30, the patient experienced nosebleed. The reporter assessed event as non-serious. No therapeutic measures were taken for the event.The patient recovered from event in 2021.  Information about lot/batch number is available. Follow-up attempts are needed.
Patient presents to the ED with complaints of nausea, vomiting and diarrhea for the past week. She also reports abdominal pain, dizziness, fatigue, lightheadedness, body aches, and chills. The patient was found to be positive for COVID-19 and a UTI. The patient will be admitted and is receiving levofloxacin, LR, ondansetron, and famotidine.
Adverse symptoms: Light-headedness, difficulty breathing, headache, fast heartbeat, laryngitis, fatigue, muscle pain/soreness. Treatment: Albuterol Oral Inhalation, Tylenol Time course: Most of the symptoms lasted between seven and nine hours after the injection. The muscle pain/soreness was the only symptom that lasted into the next day. Outcome: Most of the symptoms were gone that same evening of the injection.